Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

E-ISSN： 1996-3181|9|6|764-778

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.6, 2010-12, pp. : 764-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

By Corona Juan C Tovar-y-Romo Luis B Tapia Ricardo

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1415-1428

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic targets for amyotrophic lateral sclerosis

By Kuzma-Kozakiewicz Magdalena Kwiecinski Hubert

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 127-143

Informa Healthcare

Access to resources Recommend Favorite

Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 1, 2008-02 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 779-790

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of Immune Response in the Pathogenesis of Amyotrophic Lateral Sclerosis: A Therapeutic Opportunity?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 325-330

Bentham Science Publishers

Access to resources Recommend Favorite